4 free views remaining today

invasive aspergillosis

ICD-10 Codes

Related ICD-10:

Description

Invasive Aspergillosis: A Severe Fungal Infection

Invasive aspergillosis (IA) is a serious and potentially life-threatening infection caused by the opportunistic fungal pathogen Aspergillus fumigatus (AF). It is a hazard to patients, particularly those with weakened immune systems or lung conditions.

Characteristics of IA:

  • Severe form of infection: Invasive aspergillosis is the most severe form of infection caused by Aspergillus fungi.
  • Systemic spread: The infection can move from the lungs and spread throughout the body, affecting multiple organs and systems.
  • High mortality rate: IA has a high mortality rate, especially in immunocompromised patients.

Symptoms of Invasive Pulmonary Aspergillosis:

  • Progressive dry cough
  • Dyspnea (shortness of breath)
  • Pleuritic chest pain
  • Fever despite coverage with broad-spectrum antibiotics
  • Increased phlegm production, which may be bloody

Other symptoms:

  • Bone pain
  • Chills
  • Decreased urine output
  • Headaches
  • Skin sores (cutaneous lesions)

Causes and risk factors:

  • Weakened immune system
  • Lung conditions (e.g., cystic fibrosis, chronic obstructive pulmonary disease)
  • Immunosuppressive therapy
  • Organ transplantation

References:

  1. Invasive aspergillosis is the most severe form of infection. It occurs when the infection moves from the lungs and spreads throughout the body.[2]
  2. Rales, rhonchi, dullness to percussion, and bloody sputum or endotracheal tube secretions may be seen in invasive pulmonary aspergillosis.[3]
  3. Invasive aspergillosis is the most common mold infection in immunocompromised hosts. This infection is caused by Aspergillus, a hyaline mold.[7]
  4. Invasive aspergillosis may affect the lungs and sinuses. This can cause symptoms such as shortness of breath and

Additional Characteristics

  • Chills
  • Headaches
  • Immunosuppressive therapy
  • Invasive aspergillosis
  • The most severe form of infection caused by Aspergillus fungi.
  • The infection can move from the lungs and spread throughout the body, affecting multiple organs and systems.
  • High mortality rate, especially in immunocompromised patients.
  • Progressive dry cough
  • Dyspnea (shortness of breath)
  • Pleuritic chest pain
  • Fever despite coverage with broad-spectrum antibiotics
  • Increased phlegm production, which may be bloody
  • Bone pain
  • Decreased urine output
  • Skin sores (cutaneous lesions)
  • Weakened immune system
  • Lung conditions (e.g., cystic fibrosis, chronic obstructive pulmonary disease)
  • Organ transplantation

Signs and Symptoms

Invasive aspergillosis, a serious form of Aspergillus infection, can manifest with various signs and symptoms. According to the search results, these may include:

  • Respiratory symptoms: Coughing up blood (as mentioned in [5] and [6]), fever, chest pain, and shortness of breath ([6])
  • Systemic symptoms: Fever, chills, shock, delirium, and blood clots ([14])
  • Organ-specific symptoms: Kidney failure, liver failure (causing jaundice), and breathing difficulties may develop if the infection spreads to other organs ([14])

It's essential to note that these symptoms can vary depending on the individual and the severity of the infection. If

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Invasive Aspergillosis

Invasive aspergillosis, a serious fungal infection caused by the Aspergillus fungus, requires prompt and accurate diagnosis to initiate effective treatment. Several diagnostic tests can help identify this condition.

  • Blood Tests: Blood tests can help diagnose invasive aspergillosis early in people who have severely weakened immune systems [3]. These tests can detect the presence of Aspergillus antigens or antibodies in the blood.
  • Imaging Tests: Imaging tests such as chest X-rays, CT scans, and MRI scans can help with diagnosis by spotting a nodule or fungal mass on the lung caused by the infection [5].
  • Bronchoalveolar Lavage (BAL) and Lung Biopsy: BAL and lung biopsy are considered invasive diagnostic procedures that involve collecting a sample from the lungs to examine for Aspergillus fungus. These tests can provide a definitive diagnosis of invasive aspergillosis [4, 6].
  • Culture and Microscopic Examination: Culture and microscopic examination of respiratory specimens such as sputum or bronchoalveolar lavage fluid can also help diagnose invasive aspergillosis [1, 2].
  • Molecular Tests: Molecular tests like PCR (Polymerase Chain Reaction) can detect the genetic material of Aspergillus fungus in respiratory specimens. A combination of pan-Aspergillus PCR with BAL galactomannan testing has been shown to be highly specific and sensitive for invasive pulmonary aspergillosis [2].

It's essential to note that a combination of these diagnostic tests may be necessary to confirm the diagnosis of invasive aspergillosis.

References: [1] Oct 5, 2022 — Outline · Direct examination of respiratory specimens · Culture · Histopathology · Galactomannan antigen detection · - Interpretation · - Serum. [2] Jul 21, 2024 — Pan-Aspergillus PCR combined with BAL galactomannan testing was 97% specific and 93% sensitive for invasive pulmonary aspergillosis. Species- ... [3] Blood tests. A blood test can help diagnose invasive aspergillosis early in people who have severely weakened immune systems. Culture. [4] by T Lehrnbecher · 2018 · Cited by

Additional Diagnostic Tests

  • Imaging Tests
  • Blood Tests
  • Molecular Tests
  • Bronchoalveolar Lavage (BAL) and Lung Biopsy
  • Culture and Microscopic Examination

Treatment

Treatment Options for Invasive Aspergillosis

Invasive aspergillosis, a serious fungal infection caused by Aspergillus species, requires prompt and effective treatment to prevent complications and improve outcomes. The primary goal of treatment is to eliminate the fungus from the body.

Antifungal Medications

The mainstay of treatment for invasive aspergillosis is antifungal medications. According to recent guidelines [2], voriconazole and/or isavuconazole are recommended as the primary treatment options, with liposomal amphotericin B being a suitable alternative. These medications have been shown to be effective in treating invasive pulmonary aspergillosis [3].

Treatment Regimens

The treatment regimen for invasive aspergillosis typically involves:

  • Voriconazole or isavuconazole as the primary antifungal agent
  • Liposomal amphotericin B as an alternative or adjunct therapy
  • Combination therapy with other antifungals may be considered in certain cases

Duration of Treatment

The duration of treatment for invasive aspergillosis can vary depending on individual patient factors, such as disease severity and response to therapy. Patients who respond to initial inpatient treatment may require several weeks of antifungal therapy [6].

References:

  • [2] Guidelines recommend voriconazole and/or isavuconazole for primary treatment of IA.
  • [3] Voriconazole is recommended for most patients with invasive pulmonary aspergillosis (A-I).
  • [6] Patients who respond to initial inpatient treatment may require several weeks of antifungal therapy.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is a serious fungal infection that can be challenging to diagnose. The differential diagnosis for invasive aspergillosis includes several conditions that may present with similar symptoms and radiographic findings.

  • Asthma: Asthma can mimic the respiratory symptoms of invasive aspergillosis, such as coughing and shortness of breath [1].
  • Atypical mycobacterial infection: Atypical mycobacterial infections can cause pulmonary infiltrates and cavitations that may be similar to those seen in invasive aspergillosis [2].
  • Bacterial pneumonia:

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_142
owl#annotatedSource
t327676
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0050073
core#notation
DOID:0050073
rdf-schema#label
invasive aspergillosis
IAO_0000115
An aspergillosis that is a serious fungal infection of the lung with pneumonia caused by Aspergillus, which spreads to other parts of the body through bloodstream in patients with acute leukemia and recipients of tissue transplants. Clinical symptoms include pulmonary nodules and hemorrhage.
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_infectious_disease_slim
rdf-schema#subClassOf
t328407
RO_0004029
http://purl.obolibrary.org/obo/DOID_552
RO_0002452
http://purl.obolibrary.org/obo/SYMP_0000041
IDO_0000664
http://purl.obolibrary.org/obo/NCBITaxon_5052
RO_0004026
http://purl.obolibrary.org/obo/UBERON_0002048
relatedICD
http://example.org/icd10/B44.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.